|
Volumn 8, Issue 3, 2001, Pages 295-303
|
A combination of subtherapeutic doses of chemically modified doxycycline (CMT-8) and a bisphosphonate (Clodronate) inhibits bone loss in the ovariectomized rat: A dynamic histomorphometric and gene expression study
a b d,e d c a b b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
4 DEDIMETHYLAMINODOXYCYCLINE;
CLODRONIC ACID;
CMT 8;
COLLAGEN;
COLLAGENASE;
FLUOROCHROME;
MESSENGER RNA;
OSTEOPONTIN;
TETRACYCLINE;
TETRACYCLINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
BONE ATROPHY;
BONE MASS;
BONE STRUCTURE;
BONE TURNOVER;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DISEASE MODEL;
DOSE RESPONSE;
DOT HYBRIDIZATION;
DRUG EFFICACY;
DRUG POTENTIATION;
EXCISION;
FEEDING;
FEMALE;
FEMUR;
GENE EXPRESSION;
INHIBITION KINETICS;
MONOTHERAPY;
MORPHOMETRICS;
NEWBORN;
NONHUMAN;
NORTHERN BLOTTING;
OSTEOLYSIS;
OSTEOPOROSIS;
OVARIECTOMY;
RAT;
THICKNESS;
TIBIA;
TRABECULAR BONE;
|
EID: 0035041658
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867013373534 Document Type: Article |
Times cited : (14)
|
References (58)
|